Somatostatin Analog [EPC]

Somatostatin Analog [EPC] was reported 6873 times

Drugs of the Somatostatin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 ELECTROCARDIOGRAM T WAVE ALTERNANS 16 0.3721
3 CARCINOID CRISIS 60 0.2655
4 CARCINOID HEART DISEASE 19 0.2088
5 CORTISOL FREE URINE INCREASED 12 0.1791
6 URETHRAL CARUNCLE 10 0.1493
7 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 9 0.1343
8 SMALL INTESTINE NEUROENDOCRINE TUMOUR 7 0.1273
9 GASTRINOMA 8 0.1212
10 MICROVILLOUS INCLUSION DISEASE 8 0.1067
11 CARCINOID SYNDROME 36 0.0994
12 PROBIOTIC THERAPY 8 0.0808
13 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 19 0.0795
14 INSULINOMA 13 0.0734
15 PANCREATIC NEUROENDOCRINE TUMOUR 45 0.0702
16 CRYPTITIS 9 0.0647
17 HYPEROXALURIA 10 0.0581
18 HYPERADRENOCORTICISM 14 0.0509
19 FACTOR V INHIBITION 9 0.0464
20 BLOOD CHROMOGRANIN A INCREASED 21 0.0458
21 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 5 0.0450
22 BLOOD GROWTH HORMONE INCREASED 25 0.0448
23 CORTISOL INCREASED 27 0.0432
24 NEUROENDOCRINE CARCINOMA METASTATIC 10 0.0407
25 BILE ACID MALABSORPTION 11 0.0390
26 BLOOD CORTISOL INCREASED 10 0.0377
27 BLOOD CORTICOTROPHIN INCREASED 10 0.0346
28 APOPTOSIS 9 0.0291
29 HYPERDYNAMIC LEFT VENTRICLE 7 0.0285
30 ACROMEGALY 9 0.0284
31 SERUM SEROTONIN INCREASED 10 0.0282
32 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 6 0.0282
33 CERVIX CARCINOMA RECURRENT 5 0.0281
34 HYPERINSULINAEMIC HYPOGLYCAEMIA 6 0.0270
35 INSULIN-LIKE GROWTH FACTOR INCREASED 38 0.0266
36 INSULIN-LIKE GROWTH FACTOR DECREASED 14 0.0265
37 NEUROENDOCRINE TUMOUR 37 0.0261
38 GLUCOCORTICOID DEFICIENCY 11 0.0260
39 CHYLOTHORAX 17 0.0236
40 TACHYPHYLAXIS 8 0.0229
41 CARCINOID TUMOUR 16 0.0215
42 ADRENAL SUPPRESSION 17 0.0202
43 NECROTISING COLITIS 24 0.0189
44 NEUROENDOCRINE CARCINOMA 12 0.0173
45 CARCINOID TUMOUR PULMONARY 4 0.0166
46 BLOOD CORTISOL DECREASED 10 0.0156
47 BITE 11 0.0152
48 NECROTISING ENTEROCOLITIS NEONATAL 6 0.0148
49 CATARACT SUBCAPSULAR 9 0.0148
50 NECROTISING OESOPHAGITIS 7 0.0140
51 PLASMABLASTIC LYMPHOMA 5 0.0140
52 ABDOMINAL WALL DISORDER 4 0.0137
53 ANGIODYSPLASIA 5 0.0137
54 ATROPHIC VULVOVAGINITIS 10 0.0137
55 CRYSTAL NEPHROPATHY 8 0.0135
56 PITUITARY TUMOUR 20 0.0134
57 EHLERS-DANLOS SYNDROME 6 0.0129
58 GASTROINTESTINAL STOMA OUTPUT INCREASED 6 0.0128
59 PRODUCT INEFFECTIVE 10 0.0127
60 CORTISOL DECREASED 14 0.0122
61 UTERINE MASS 5 0.0121
62 GASTROINTESTINAL STOMA COMPLICATION 19 0.0121
63 GASTRIC ANTRAL VASCULAR ECTASIA 6 0.0113
64 METASTASES TO PANCREAS 5 0.0113
65 EROSIVE DUODENITIS 9 0.0112
66 GLOMERULOSCLEROSIS 7 0.0111
67 HYDROTHORAX 9 0.0108
68 LIGHT CHAIN ANALYSIS INCREASED 11 0.0106
69 LYMPHATIC DISORDER 6 0.0101
70 TERMINAL ILEITIS 6 0.0098
71 SINUS ARREST 15 0.0096
72 METASTASES TO PELVIS 6 0.0095
73 HYPOGONADISM 9 0.0089
74 HYPOGLYCAEMIC SEIZURE 8 0.0088
75 ROTAVIRUS INFECTION 5 0.0087
76 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 22 0.0083
77 ADENOMA BENIGN 7 0.0081
78 PITUITARY TUMOUR BENIGN 13 0.0080
79 FAECAL VOLUME INCREASED 4 0.0077
80 RECTAL ULCER 9 0.0077
81 ENCEPHALITIS AUTOIMMUNE 10 0.0076
82 BIOPSY 7 0.0076
83 PULMONARY VALVE INCOMPETENCE 11 0.0075
84 APRAXIA 11 0.0074
85 CELL DEATH 14 0.0071
86 PANCREATIC FAILURE 12 0.0068
87 LIVER ABSCESS 22 0.0068
88 LABILE BLOOD PRESSURE 8 0.0067
89 CYTOGENETIC ANALYSIS ABNORMAL 7 0.0067
90 TUMOUR NECROSIS 7 0.0066
91 HEPATIC NEOPLASM 21 0.0064
92 RIGHT VENTRICULAR DYSFUNCTION 7 0.0063
93 IIIRD NERVE PARALYSIS 5 0.0062
94 METASTASES TO LIVER 106 0.0060
95 FUNGAL SEPSIS 5 0.0060
96 STOMA COMPLICATION 6 0.0059
97 SEIZURE LIKE PHENOMENA 10 0.0059
98 HEPATIC CANCER METASTATIC 5 0.0058
99 GASTROINTESTINAL NEOPLASM 5 0.0058
100 ADRENOCORTICAL INSUFFICIENCY ACUTE 11 0.0056
101 CUSHINGOID 18 0.0056
102 ABDOMINAL NEOPLASM 5 0.0056
103 HEPATIC LESION 24 0.0055
104 BLOOD PRESSURE SYSTOLIC INCREASED 105 0.0054
105 HYPERGLYCAEMIA 192 0.0053
106 RADIOTHERAPY 10 0.0052
107 PAROTITIS 6 0.0052
108 INTRA-ABDOMINAL HAEMORRHAGE 12 0.0050
109 METASTASES TO SKIN 5 0.0048
110 CAPILLARY LEAK SYNDROME 10 0.0048
111 BLOOD SODIUM INCREASED 13 0.0048
112 BLOOD PARATHYROID HORMONE INCREASED 14 0.0048
113 SYSTOLIC DYSFUNCTION 5 0.0047
114 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 10 0.0047
115 BLOOD CHLORIDE DECREASED 12 0.0046
116 OESOPHAGEAL VARICES HAEMORRHAGE 10 0.0046
117 HYPOPITUITARISM 8 0.0046
118 DIABETES INSIPIDUS 11 0.0046
119 PNEUMATOSIS INTESTINALIS 13 0.0046
120 HYPOGLYCAEMIA 220 0.0045
121 CEREBRAL HAEMATOMA 15 0.0045
122 CANDIDA SEPSIS 4 0.0045
123 SKIN NECROSIS 23 0.0044
124 FAECAL CALPROTECTIN INCREASED 14 0.0044
125 ADRENAL INSUFFICIENCY 53 0.0044
126 CHOLECYSTITIS INFECTIVE 12 0.0043
127 SHOCK HAEMORRHAGIC 35 0.0043
128 BRASH SYNDROME 6 0.0043
129 VASOPLEGIA SYNDROME 7 0.0043
130 BILIARY COLIC 12 0.0041
131 PERFORMANCE STATUS DECREASED 19 0.0041
132 BODY TEMPERATURE DECREASED 40 0.0041
133 BLOOD PHOSPHORUS INCREASED 11 0.0040
134 RUBBER SENSITIVITY 6 0.0039
135 UTERINE POLYP 7 0.0039
136 BILIARY OBSTRUCTION 5 0.0039
137 VITAMIN B12 DECREASED 11 0.0038
138 TUMOUR PAIN 5 0.0038
139 PNEUMOPERITONEUM 7 0.0038
140 ENTERITIS 24 0.0037
141 HEPATIC PAIN 16 0.0037
142 BONE NEOPLASM 4 0.0037
143 INCISIONAL HERNIA 5 0.0036
144 CHOLELITHIASIS 117 0.0036
145 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
146 HEPATORENAL SYNDROME 6 0.0036
147 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 194 0.0035
148 CACHEXIA 18 0.0035
149 KIDNEY FIBROSIS 6 0.0035
150 BILE DUCT STONE 11 0.0035
151 HYPERVOLAEMIA 17 0.0034
152 SMALL INTESTINAL OBSTRUCTION 42 0.0034
153 SUBILEUS 7 0.0034
154 ESCHERICHIA TEST POSITIVE 4 0.0033
155 STEROID DIABETES 5 0.0033
156 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
157 DUODENITIS 10 0.0033
158 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
159 STOMA SITE HAEMORRHAGE 5 0.0032
160 RASH MORBILLIFORM 9 0.0032
161 GASTRIC ULCER PERFORATION 4 0.0032
162 HEART VALVE INCOMPETENCE 9 0.0031
163 HEPATIC MASS 6 0.0031
164 HYPOGLYCAEMIA NEONATAL 5 0.0031
165 CALCIUM DEFICIENCY 4 0.0031
166 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
167 POLYDIPSIA 12 0.0030
168 STEATORRHOEA 8 0.0030
169 DEVICE RELATED SEPSIS 6 0.0030
170 VARICES OESOPHAGEAL 9 0.0030
171 LIBIDO INCREASED 6 0.0030
172 NEOPLASM 34 0.0030
173 COLITIS MICROSCOPIC 14 0.0030
174 VOLVULUS 7 0.0030
175 SECOND PRIMARY MALIGNANCY 24 0.0029
176 NEOPLASM PROGRESSION 99 0.0028
177 AORTIC VALVE INCOMPETENCE 12 0.0028
178 METASTASES TO BONE 46 0.0028
179 METASTASIS 20 0.0028
180 LYMPHOCYTOSIS 6 0.0028
181 ERYSIPELAS 14 0.0028
182 PORTAL VEIN THROMBOSIS 9 0.0028
183 LYMPHOCYTE COUNT INCREASED 9 0.0028
184 BILIARY DILATATION 4 0.0027
185 CEREBROSPINAL FLUID LEAKAGE 5 0.0027
186 FAECES PALE 6 0.0027
187 RECURRENT CANCER 11 0.0027
188 FAILURE TO THRIVE 14 0.0027
189 BACTERIAL TEST POSITIVE 6 0.0027
190 POLYURIA 22 0.0027
191 NEOPLASM RECURRENCE 9 0.0027
192 MALIGNANT NEOPLASM PROGRESSION 268 0.0026
193 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
194 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
195 CONCOMITANT DISEASE PROGRESSION 5 0.0026
196 RESPIRATORY ACIDOSIS 10 0.0025
197 PHLEBITIS 13 0.0025
198 HYPOGLYCAEMIC UNCONSCIOUSNESS 5 0.0025
199 MALABSORPTION 13 0.0025
200 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
201 HEPATIC ENCEPHALOPATHY 23 0.0025
202 VASCULAR DEVICE INFECTION 11 0.0024
203 CHOLANGITIS 15 0.0024
204 PROTEIN URINE PRESENT 12 0.0024
205 NOCTURIA 29 0.0024
206 ENTEROBACTER INFECTION 4 0.0024
207 THERAPY NON-RESPONDER 107 0.0024
208 HAEMODYNAMIC INSTABILITY 18 0.0024
209 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
210 CANCER PAIN 6 0.0023
211 BLOOD CHLORIDE INCREASED 4 0.0023
212 DIABETES MELLITUS 176 0.0023
213 BLOOD IRON DECREASED 27 0.0023
214 RETROPERITONEAL HAEMATOMA 5 0.0023
215 HORMONE LEVEL ABNORMAL 11 0.0023
216 MALNUTRITION 25 0.0022
217 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
218 CARDIOMYOPATHY 33 0.0022
219 ASCITES 65 0.0022
220 SINUS BRADYCARDIA 21 0.0022
221 ENCEPHALITIS 15 0.0022
222 TUMOUR HAEMORRHAGE 6 0.0021
223 SLEEP APNOEA SYNDROME 40 0.0021
224 METASTASES TO SPINE 7 0.0021
225 ADENOVIRUS INFECTION 6 0.0021
226 HYPOVOLAEMIA 12 0.0020
227 INJECTION SITE ABSCESS 5 0.0020
228 NEEDLE ISSUE 58 0.0020
229 HYPERCHOLESTEROLAEMIA 19 0.0020
230 LUMBAR VERTEBRAL FRACTURE 9 0.0020
231 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
232 ABNORMAL FAECES 16 0.0020
233 CARDIAC FAILURE ACUTE 13 0.0019
234 PORTAL HYPERTENSION 6 0.0019
235 CARDIAC VALVE DISEASE 11 0.0019
236 INJECTION SITE HYPERSENSITIVITY 6 0.0019
237 URINE OUTPUT INCREASED 5 0.0019
238 FAECES DISCOLOURED 41 0.0019
239 ABSCESS LIMB 8 0.0019
240 ABDOMINAL MASS 5 0.0019
241 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
242 BACTERIAL SEPSIS 6 0.0018
243 NORMAL NEWBORN 10 0.0018
244 HEPATOMEGALY 18 0.0018
245 GRAFT VERSUS HOST DISEASE 13 0.0018
246 INTESTINAL OBSTRUCTION 68 0.0018
247 RESPIRATORY RATE INCREASED 16 0.0018
248 HYPERAMMONAEMIA 9 0.0018
249 MUSCLE RUPTURE 7 0.0018
250 CHOLESTATIC LIVER INJURY 4 0.0018
251 DIABETIC COMA 5 0.0018
252 BK VIRUS INFECTION 6 0.0018
253 METASTASES TO LYMPH NODES 12 0.0018
254 GENERALISED OEDEMA 22 0.0018
255 DISEASE PROGRESSION 210 0.0018
256 CHOLECYSTITIS ACUTE 10 0.0018
257 TRICUSPID VALVE INCOMPETENCE 14 0.0018
258 HYPOPHOSPHATAEMIA 13 0.0018
259 HYPOCALCAEMIA 33 0.0017
260 HYPOGLYCAEMIC COMA 5 0.0017
261 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
262 FLATULENCE 98 0.0017
263 METABOLIC DISORDER 10 0.0017
264 ELECTROLYTE IMBALANCE 20 0.0017
265 DEFAECATION URGENCY 12 0.0017
266 GOITRE 7 0.0017
267 BLOOD LACTIC ACID INCREASED 9 0.0017
268 JAUNDICE CHOLESTATIC 6 0.0017
269 GROWTH RETARDATION 5 0.0017
270 ACUTE HEPATIC FAILURE 23 0.0017
271 TUMOUR MARKER INCREASED 8 0.0017
272 FACIAL BONES FRACTURE 6 0.0017
273 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0016
274 BLOOD GLUCOSE FLUCTUATION 18 0.0016
275 VITAMIN D DEFICIENCY 16 0.0016
276 BLOOD MAGNESIUM DECREASED 14 0.0016
277 DIASTOLIC DYSFUNCTION 5 0.0016
278 THERAPY PARTIAL RESPONDER 25 0.0016
279 BLOOD CALCIUM DECREASED 18 0.0016
280 AUTOIMMUNE HEPATITIS 11 0.0016
281 COAGULOPATHY 26 0.0016
282 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
283 FAECES HARD 6 0.0015
284 RHINOVIRUS INFECTION 6 0.0015
285 INJECTION SITE EXTRAVASATION 19 0.0015
286 BLOOD GLUCOSE DECREASED 73 0.0015
287 HEPATIC STEATOSIS 28 0.0015
288 FLANK PAIN 14 0.0015
289 COMPRESSION FRACTURE 8 0.0015
290 THYROID DISORDER 23 0.0015
291 BREAST MASS 10 0.0015
292 EXTRAVASATION 6 0.0015
293 HEPATIC FAILURE 44 0.0015
294 VENTRICULAR TACHYCARDIA 24 0.0015
295 BOWEL MOVEMENT IRREGULARITY 11 0.0014
296 NEPHROPATHY TOXIC 16 0.0014
297 BRAIN NEOPLASM 13 0.0014
298 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
299 MULTIPLE ORGAN DYSFUNCTION SYNDROME 40 0.0014
300 HYPOKALAEMIA 65 0.0014
301 UTERINE HAEMORRHAGE 6 0.0014
302 METASTATIC NEOPLASM 6 0.0014
303 BONE LESION 5 0.0014
304 PERICARDIAL EFFUSION 32 0.0014
305 MOTOR DYSFUNCTION 14 0.0014
306 FREQUENT BOWEL MOVEMENTS 37 0.0014
307 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
308 RECTAL DISCHARGE 5 0.0014
309 ABDOMINAL ABSCESS 6 0.0014
310 AMYLASE INCREASED 5 0.0014
311 TERMINAL STATE 9 0.0013
312 CHOLECYSTITIS 16 0.0013
313 HEART RATE DECREASED 47 0.0013
314 FLUSHING 136 0.0013
315 CYTOMEGALOVIRUS INFECTION 22 0.0013
316 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
317 EMBOLISM VENOUS 4 0.0013
318 MELAENA 29 0.0013
319 ANAL FISTULA 7 0.0013
320 ACIDOSIS 10 0.0013
321 ELECTROCARDIOGRAM QT PROLONGED 47 0.0013
322 ISCHAEMIA 6 0.0013
323 HYPOMAGNESAEMIA 18 0.0013
324 OLIGURIA 8 0.0013
325 HEART RATE IRREGULAR 29 0.0013
326 ANURIA 11 0.0013
327 BLOOD CREATININE DECREASED 4 0.0013
328 VENOUS THROMBOSIS 5 0.0013
329 SKIN ABRASION 6 0.0013
330 BLOOD PRESSURE DECREASED 84 0.0013
331 FURUNCLE 10 0.0013
332 BLADDER PAIN 4 0.0013
333 GASTROINTESTINAL HAEMORRHAGE 105 0.0013
334 TUMOUR LYSIS SYNDROME 11 0.0012
335 ACUTE PULMONARY OEDEMA 7 0.0012
336 INTESTINAL PERFORATION 14 0.0012
337 ARTERIOSPASM CORONARY 5 0.0012
338 DRUG RESISTANCE 32 0.0012
339 VISUAL FIELD DEFECT 9 0.0012
340 REBOUND EFFECT 14 0.0012
341 VITAMIN B12 DEFICIENCY 5 0.0012
342 DEVICE RELATED INFECTION 19 0.0012
343 ABDOMINAL PAIN 284 0.0012
344 HYPERURICAEMIA 5 0.0012
345 EMBOLISM 10 0.0012
346 FLUID INTAKE REDUCED 6 0.0012
347 BLOOD POTASSIUM DECREASED 36 0.0012
348 HYPERTRIGLYCERIDAEMIA 7 0.0012
349 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
350 LYMPHOCYTE COUNT DECREASED 21 0.0012
351 KLEBSIELLA INFECTION 6 0.0012
352 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
353 BLOOD PRESSURE INCREASED 181 0.0012
354 NERVE INJURY 13 0.0012
355 HEPATITIS B 7 0.0012
356 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
357 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
358 CHOLESTASIS 22 0.0011
359 PULMONARY MASS 17 0.0011
360 INJECTION SITE DISCOMFORT 12 0.0011
361 BLOOD UREA INCREASED 19 0.0011
362 TYPE 2 DIABETES MELLITUS 38 0.0011
363 ILEUS 14 0.0011
364 METASTASES TO LUNG 13 0.0011
365 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
366 ILEUS PARALYTIC 5 0.0011
367 FRUSTRATION TOLERANCE DECREASED 9 0.0011
368 BRADYCARDIA 59 0.0011
369 IRON DEFICIENCY 5 0.0011
370 BLOOD POTASSIUM INCREASED 18 0.0011
371 URINE ABNORMALITY 5 0.0011
372 TOXIC SKIN ERUPTION 11 0.0011
373 BLOOD GLUCOSE ABNORMAL 20 0.0011
374 ABDOMINAL DISTENSION 113 0.0011
375 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
376 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
377 COLITIS 41 0.0011
378 HAEMORRHOIDS 21 0.0011
379 ABDOMINAL PAIN LOWER 27 0.0011
380 HAEMATOCRIT DECREASED 21 0.0011
381 PLEURAL EFFUSION 64 0.0011
382 RED BLOOD CELL COUNT DECREASED 30 0.0010
383 ACUTE KIDNEY INJURY 160 0.0010
384 CARDIOGENIC SHOCK 15 0.0010
385 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
386 SEPTIC SHOCK 45 0.0010
387 HYPOALBUMINAEMIA 8 0.0010
388 INJECTION SITE MASS 38 0.0010
389 DIARRHOEA 663 0.0010
390 ENCEPHALOPATHY 25 0.0010
391 PANCREATIC DISORDER 5 0.0010
392 BACTERAEMIA 12 0.0010
393 PRODUCT PRESCRIBING ISSUE 22 0.0010
394 PNEUMOTHORAX 16 0.0010
395 BLOOD ALBUMIN DECREASED 8 0.0010
396 PROTEINURIA 19 0.0010
397 HYPERKALAEMIA 35 0.0010
398 PULMONARY TOXICITY 7 0.0010
399 DERMATITIS ACNEIFORM 6 0.0010
400 DYSLIPIDAEMIA 5 0.0010
401 POST PROCEDURAL INFECTION 8 0.0010
402 RESPIRATORY DEPRESSION 12 0.0010
403 OFF LABEL USE 856 0.0010
404 MUSCULOSKELETAL CHEST PAIN 15 0.0010
405 VARICOSE VEIN 5 0.0010
406 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
407 THROMBOCYTOPENIA 108 0.0010
408 CHOLECYSTECTOMY 11 0.0010
409 DIARRHOEA HAEMORRHAGIC 9 0.0010
410 GASTROENTERITIS 14 0.0010
411 GALLBLADDER DISORDER 17 0.0010
412 RENAL PAIN 10 0.0009
413 SEPSIS 105 0.0009
414 LEUKOCYTOSIS 17 0.0009
415 EATING DISORDER 20 0.0009
416 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
417 PROCTALGIA 6 0.0009
418 OVERWEIGHT 5 0.0009
419 MASS 13 0.0009
420 DIZZINESS POSTURAL 9 0.0009
421 MYOPATHY 8 0.0009
422 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
423 OSTEOPENIA 14 0.0009
424 BLOOD GLUCOSE INCREASED 173 0.0009
425 PNEUMONITIS 25 0.0009
426 HEPATOCELLULAR INJURY 13 0.0009
427 POLYP 6 0.0009
428 SYRINGE ISSUE 16 0.0009
429 HYPOGAMMAGLOBULINAEMIA 6 0.0009
430 PULMONARY HYPERTENSION 19 0.0009
431 HOSPICE CARE 9 0.0009
432 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
433 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
434 STREPTOCOCCAL INFECTION 5 0.0009
435 PULMONARY HAEMORRHAGE 7 0.0009
436 GASTROINTESTINAL INFECTION 8 0.0009
437 TORSADE DE POINTES 7 0.0009
438 ANAL INCONTINENCE 8 0.0009
439 HYPOTHERMIA 9 0.0009
440 BLOOD BILIRUBIN INCREASED 24 0.0009
441 WEIGHT DECREASED 248 0.0009
442 HAEMATOMA 23 0.0009
443 COLECTOMY 5 0.0009
444 LIVER FUNCTION TEST INCREASED 19 0.0009
445 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
446 GENERAL PHYSICAL HEALTH DETERIORATION 102 0.0009
447 HYPOXIA 31 0.0009
448 DYSPNOEA EXERTIONAL 33 0.0009
449 METABOLIC ACIDOSIS 28 0.0009
450 ECCHYMOSIS 6 0.0009
451 EAR DISORDER 4 0.0009
452 NEPHROLITHIASIS 40 0.0009
453 URINARY RETENTION 29 0.0009
454 EXERCISE TOLERANCE DECREASED 5 0.0009
455 IRON DEFICIENCY ANAEMIA 8 0.0009
456 ENTEROCOLITIS 5 0.0009
457 DECREASED APPETITE 199 0.0009
458 PRODUCT USE IN UNAPPROVED INDICATION 212 0.0009
459 HEPATIC CIRRHOSIS 16 0.0009
460 DUODENAL ULCER 6 0.0008
461 ENERGY INCREASED 5 0.0008
462 DEHYDRATION 112 0.0008
463 GESTATIONAL DIABETES 4 0.0008
464 GAIT INABILITY 28 0.0008
465 HAEMATOCHEZIA 46 0.0008
466 BODY TEMPERATURE INCREASED 17 0.0008
467 HAEMATEMESIS 21 0.0008
468 DRUG INTOLERANCE 80 0.0008
469 ENTEROCOCCAL INFECTION 4 0.0008
470 SKIN LACERATION 9 0.0008
471 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
472 PANCYTOPENIA 46 0.0008
473 QUALITY OF LIFE DECREASED 11 0.0008
474 CYTOPENIA 10 0.0008
475 KIDNEY INFECTION 16 0.0008
476 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
477 TREATMENT FAILURE 67 0.0008
478 LIMB DISCOMFORT 25 0.0008
479 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 145 0.0008
480 OSTEOPOROSIS 33 0.0008
481 HYDRONEPHROSIS 6 0.0008
482 PANCREATITIS ACUTE 18 0.0008
483 CARDIAC ARREST 66 0.0008
484 PRODUCT USE ISSUE 149 0.0008
485 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
486 STOMATITIS 48 0.0008
487 BLOOD URINE PRESENT 15 0.0008
488 HAEMOPTYSIS 22 0.0008
489 EYELID PTOSIS 8 0.0008
490 HEPATIC CYTOLYSIS 10 0.0008
491 RIB FRACTURE 16 0.0008
492 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
493 HYPERBILIRUBINAEMIA 8 0.0008
494 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
495 EJECTION FRACTION DECREASED 12 0.0008
496 PALLOR 21 0.0008
497 GASTROINTESTINAL CARCINOMA 7 0.0008
498 HEPATOTOXICITY 17 0.0008
499 HYPERTHYROIDISM 11 0.0008
500 THERAPEUTIC RESPONSE DECREASED 46 0.0008
501 PRODUCTIVE COUGH 36 0.0008
502 MULTI-ORGAN FAILURE 13 0.0008
503 BLOOD PRESSURE FLUCTUATION 18 0.0007
504 HAEMOGLOBIN DECREASED 77 0.0007
505 FOOD POISONING 4 0.0007
506 HYPOPHAGIA 19 0.0007
507 HYPOTENSION 149 0.0007
508 BLOOD SODIUM DECREASED 14 0.0007
509 URINARY INCONTINENCE 22 0.0007
510 POSTOPERATIVE WOUND INFECTION 5 0.0007
511 OEDEMA PERIPHERAL 90 0.0007
512 SPUTUM DISCOLOURED 7 0.0007
513 PANCREATITIS 39 0.0007
514 PRODUCT PACKAGING ISSUE 7 0.0007
515 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
516 TACHYPNOEA 10 0.0007
517 HEPATIC ENZYME INCREASED 50 0.0007
518 ASPIRATION 8 0.0007
519 LETHARGY 42 0.0007
520 RENAL DISORDER 34 0.0007
521 THIRST 13 0.0007
522 GASTROINTESTINAL PAIN 8 0.0007
523 RENAL IMPAIRMENT 61 0.0007
524 MUCOSAL INFLAMMATION 19 0.0007
525 LYMPHOEDEMA 5 0.0007
526 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
527 LIVER DISORDER 32 0.0007
528 ANAEMIA 137 0.0007
529 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
530 CONTUSION 69 0.0007
531 HYPERTENSION 150 0.0007
532 MYOCARDIAL ISCHAEMIA 8 0.0007
533 SCAB 8 0.0007
534 OEDEMA 38 0.0007
535 PRODUCT SUPPLY ISSUE 5 0.0007
536 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
537 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
538 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
539 DISEASE RECURRENCE 33 0.0007
540 MUSCLE STRAIN 6 0.0007
541 CARDIAC MURMUR 6 0.0007
542 GASTROINTESTINAL DISORDER 62 0.0007
543 SCIATICA 11 0.0007
544 ABDOMINAL PAIN UPPER 142 0.0007
545 BLOOD CREATININE INCREASED 45 0.0007
546 RESPIRATORY FAILURE 50 0.0007
547 SPINAL PAIN 8 0.0007
548 COLD SWEAT 12 0.0007
549 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
550 POST PROCEDURAL COMPLICATION 13 0.0007
551 VENTRICULAR EXTRASYSTOLES 7 0.0007
552 HERNIA 13 0.0007
553 NAUSEA 532 0.0007
554 TENDERNESS 7 0.0007
555 PETECHIAE 7 0.0007
556 DRUG INTERACTION 105 0.0007
557 HYPOTHYROIDISM 21 0.0007
558 HOSPITALISATION 101 0.0007
559 CARDIOMEGALY 8 0.0006
560 FEBRILE NEUTROPENIA 43 0.0006
561 HYPERCALCAEMIA 8 0.0006
562 NEPHROPATHY 6 0.0006
563 VOMITING 302 0.0006
564 MUSCULOSKELETAL DISCOMFORT 11 0.0006
565 GASTROINTESTINAL INFLAMMATION 5 0.0006
566 MUSCLE ATROPHY 8 0.0006
567 PREMATURE BABY 19 0.0006
568 SYNCOPE 63 0.0006
569 OBESITY 10 0.0006
570 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
571 DRUG INEFFECTIVE 826 0.0006
572 CARDIAC FAILURE 50 0.0006
573 ATELECTASIS 6 0.0006
574 PRESYNCOPE 15 0.0006
575 ANGINA UNSTABLE 4 0.0006
576 INTERNAL HAEMORRHAGE 7 0.0006
577 THERAPY CHANGE 6 0.0006
578 ASPERGILLUS INFECTION 4 0.0006
579 GASTRIC HAEMORRHAGE 7 0.0006
580 TOOTH INFECTION 8 0.0006
581 PULMONARY CONGESTION 8 0.0006
582 INFLAMMATION 31 0.0006
583 JAUNDICE 16 0.0006
584 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
585 SKIN PLAQUE 5 0.0006
586 BACTERIAL INFECTION 11 0.0006
587 ASTHENIA 221 0.0006
588 CIRCULATORY COLLAPSE 10 0.0006
589 VITAMIN D DECREASED 5 0.0006
590 EAR DISCOMFORT 6 0.0006
591 PSEUDOMONAS INFECTION 5 0.0006
592 DYSSTASIA 17 0.0006
593 BONE PAIN 34 0.0006
594 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
595 FATIGUE 450 0.0006
596 PERIPHERAL SWELLING 89 0.0006
597 DELIRIUM 20 0.0006
598 ORTHOSTATIC HYPOTENSION 10 0.0006
599 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
600 DYSURIA 21 0.0006
601 BLOOD CALCIUM INCREASED 5 0.0006
602 GROIN PAIN 5 0.0006
603 SHOCK 13 0.0006
604 URINARY TRACT INFECTION 96 0.0006
605 HAIR COLOUR CHANGES 7 0.0006
606 FACIAL PAIN 5 0.0006
607 HYPERHIDROSIS 72 0.0006
608 GOUT 10 0.0006
609 CONSTIPATION 121 0.0006
610 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
611 TACHYCARDIA 49 0.0006
612 PELVIC PAIN 10 0.0005
613 FLUID OVERLOAD 8 0.0005
614 WOUND INFECTION 6 0.0005
615 ILL-DEFINED DISORDER 33 0.0005
616 OSTEOARTHRITIS 23 0.0005
617 UNRESPONSIVE TO STIMULI 14 0.0005
618 OVARIAN CANCER 5 0.0005
619 TASTE DISORDER 11 0.0005
620 UROSEPSIS 5 0.0005
621 DRUG-INDUCED LIVER INJURY 17 0.0005
622 CEREBRAL DISORDER 4 0.0005
623 TRANSAMINASES INCREASED 12 0.0005
624 FEELING COLD 15 0.0005
625 COLON CANCER 8 0.0005
626 WOUND 15 0.0005
627 CONDITION AGGRAVATED 163 0.0005
628 INJECTION SITE SWELLING 41 0.0005
629 CANDIDA INFECTION 9 0.0005
630 THERAPY INTERRUPTED 38 0.0005
631 LOSS OF CONSCIOUSNESS 68 0.0005
632 LEUKAEMIA 5 0.0005
633 RHABDOMYOLYSIS 22 0.0005
634 HAEMATURIA 18 0.0005
635 PLATELET COUNT DECREASED 56 0.0005
636 MICTURITION URGENCY 6 0.0005
637 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
638 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
639 EPILEPSY 16 0.0005
640 C-REACTIVE PROTEIN INCREASED 19 0.0005
641 OROPHARYNGEAL PAIN 48 0.0005
642 ERUCTATION 10 0.0005
643 PULMONARY EMBOLISM 49 0.0005
644 STAPHYLOCOCCAL INFECTION 17 0.0005
645 APNOEA 4 0.0005
646 MOOD ALTERED 14 0.0005
647 PERIPHERAL COLDNESS 7 0.0005
648 HEPATIC FUNCTION ABNORMAL 19 0.0005
649 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
650 RESPIRATORY DISTRESS 14 0.0005
651 LIGAMENT SPRAIN 5 0.0005
652 DIVERTICULITIS 14 0.0005
653 MENTAL STATUS CHANGES 14 0.0005
654 BLOOD PRESSURE ABNORMAL 10 0.0005
655 SKIN DISCOLOURATION 23 0.0005
656 CYTOKINE RELEASE SYNDROME 10 0.0005
657 PRODUCT ADMINISTRATION ERROR 10 0.0005
658 EPISTAXIS 37 0.0005
659 BURSITIS 6 0.0005
660 NEOPLASM MALIGNANT 33 0.0005
661 FEEDING DISORDER 10 0.0005
662 TOOTH ABSCESS 5 0.0005
663 DECUBITUS ULCER 4 0.0005
664 DEATH 422 0.0005
665 RECTAL HAEMORRHAGE 21 0.0005
666 MYELODYSPLASTIC SYNDROME 7 0.0005
667 LIVER FUNCTION TEST ABNORMAL 14 0.0005
668 DEEP VEIN THROMBOSIS 31 0.0005
669 RENAL FAILURE 63 0.0005
670 HEAD INJURY 15 0.0005
671 INCONTINENCE 5 0.0005
672 FULL BLOOD COUNT ABNORMAL 5 0.0005
673 MALAISE 207 0.0005
674 HAEMORRHAGE 49 0.0005
675 JOINT INJURY 10 0.0005
676 HIP FRACTURE 15 0.0005
677 ILLNESS 48 0.0005
678 CARDIAC OPERATION 4 0.0005
679 PYREXIA 161 0.0005
680 GAIT DISTURBANCE 89 0.0005
681 ABDOMINAL DISCOMFORT 78 0.0005
682 HEART RATE INCREASED 46 0.0005
683 INJECTION SITE HAEMORRHAGE 37 0.0005
684 INJECTION SITE PAIN 142 0.0005
685 NEUROPATHY PERIPHERAL 44 0.0005
686 HYPONATRAEMIA 26 0.0005
687 RASH ERYTHEMATOUS 22 0.0005
688 HIP ARTHROPLASTY 7 0.0005
689 POLLAKIURIA 19 0.0005
690 INJECTION SITE NODULE 5 0.0005
691 DIZZINESS 225 0.0005
692 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 32 0.0004
693 RASH MACULO-PAPULAR 10 0.0004
694 MALIGNANT MELANOMA 6 0.0004
695 FALL 149 0.0004
696 FISTULA 5 0.0004
697 LIMB INJURY 12 0.0004
698 MITRAL VALVE INCOMPETENCE 5 0.0004
699 MUSCULAR WEAKNESS 50 0.0004
700 PREMATURE DELIVERY 7 0.0004
701 SLEEP DISORDER 31 0.0004
702 INJECTION SITE WARMTH 9 0.0004
703 PRODUCT SUBSTITUTION ISSUE 25 0.0004
704 CONFUSIONAL STATE 70 0.0004
705 PROCEDURAL PAIN 12 0.0004
706 FLUID RETENTION 22 0.0004
707 HEPATITIS 11 0.0004
708 SEIZURE 49 0.0004
709 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
710 SINUS TACHYCARDIA 6 0.0004
711 RETCHING 9 0.0004
712 CHRONIC KIDNEY DISEASE 32 0.0004
713 MUSCULOSKELETAL PAIN 22 0.0004
714 ACCIDENT 5 0.0004
715 HYPERSOMNIA 12 0.0004
716 CHILLS 49 0.0004
717 BACK PAIN 97 0.0004
718 DIABETIC KETOACIDOSIS 10 0.0004
719 CHEST PAIN 77 0.0004
720 PANCREATIC CARCINOMA 12 0.0004
721 PRODUCT DOSE OMISSION ISSUE 122 0.0004
722 JOINT SWELLING 50 0.0004
723 LOCALISED INFECTION 10 0.0004
724 HYPOKINESIA 6 0.0004
725 CRYING 15 0.0004
726 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
727 NO THERAPEUTIC RESPONSE 5 0.0004
728 INFECTION 59 0.0004
729 MOVEMENT DISORDER 13 0.0004
730 BLADDER DISORDER 4 0.0004
731 TREATMENT NONCOMPLIANCE 22 0.0004
732 UPPER LIMB FRACTURE 8 0.0004
733 CHEST DISCOMFORT 41 0.0004
734 COMA 19 0.0004
735 BRAIN INJURY 4 0.0004
736 HEADACHE 250 0.0004
737 DYSARTHRIA 15 0.0004
738 EMPHYSEMA 4 0.0004
739 BRAIN OEDEMA 5 0.0004
740 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
741 DRY MOUTH 32 0.0004
742 BONE MARROW FAILURE 8 0.0004
743 BALANCE DISORDER 34 0.0004
744 BLINDNESS 16 0.0004
745 INSURANCE ISSUE 6 0.0004
746 CEREBRAL HAEMORRHAGE 14 0.0004
747 NEUTROPENIA 53 0.0004
748 THERAPY CESSATION 20 0.0004
749 LYMPHOMA 6 0.0004
750 INJECTION SITE INDURATION 5 0.0004
751 ANGINA PECTORIS 11 0.0004
752 DYSPNOEA 217 0.0004
753 NERVOUSNESS 20 0.0004
754 SOMNOLENCE 77 0.0004
755 CYANOSIS 6 0.0004
756 INCORRECT PRODUCT STORAGE 5 0.0004
757 BEDRIDDEN 5 0.0004
758 WEIGHT INCREASED 85 0.0004
759 VERTIGO 23 0.0004
760 ULCER 6 0.0004
761 DISCOMFORT 23 0.0004
762 DYSGEUSIA 28 0.0004
763 CYSTITIS 12 0.0004
764 NASAL CONGESTION 22 0.0004
765 BODY HEIGHT DECREASED 4 0.0004
766 OXYGEN SATURATION DECREASED 21 0.0004
767 FOETAL EXPOSURE DURING PREGNANCY 30 0.0004
768 RESPIRATORY DISORDER 11 0.0004
769 PNEUMONIA 119 0.0004
770 LYMPHADENOPATHY 13 0.0004
771 PALPITATIONS 43 0.0004
772 IMPAIRED GASTRIC EMPTYING 5 0.0004
773 LIVER INJURY 9 0.0004
774 LOWER LIMB FRACTURE 7 0.0004
775 LACRIMATION INCREASED 11 0.0004
776 CORONARY ARTERY DISEASE 11 0.0004
777 DRUG LEVEL INCREASED 6 0.0004
778 ALOPECIA 71 0.0004
779 ATRIAL FIBRILLATION 35 0.0004
780 APHONIA 5 0.0004
781 RASH PAPULAR 8 0.0004
782 RHINORRHOEA 23 0.0004
783 MUSCLE SPASMS 65 0.0004
784 LYMPHOPENIA 5 0.0004
785 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
786 PAIN IN EXTREMITY 104 0.0004
787 SCAR 6 0.0004
788 SPINAL FRACTURE 7 0.0003
789 PARALYSIS 5 0.0003
790 MATERNAL EXPOSURE DURING PREGNANCY 31 0.0003
791 DYSPEPSIA 34 0.0003
792 NEUROTOXICITY 6 0.0003
793 NASOPHARYNGITIS 63 0.0003
794 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
795 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
796 PERITONITIS 7 0.0003
797 SWELLING FACE 22 0.0003
798 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
799 PAIN 207 0.0003
800 THROMBOSIS 27 0.0003
801 MYELOSUPPRESSION 12 0.0003
802 MOUTH ULCERATION 7 0.0003
803 HOT FLUSH 25 0.0003
804 RESTLESS LEGS SYNDROME 6 0.0003
805 RENAL FAILURE ACUTE 14 0.0003
806 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
807 DEMENTIA 9 0.0003
808 DEPRESSED MOOD 17 0.0003
809 COUGH 90 0.0003
810 ERYTHEMA 65 0.0003
811 INTENTIONAL DOSE OMISSION 9 0.0003
812 INCREASED APPETITE 6 0.0003
813 ABSCESS 5 0.0003
814 HERPES ZOSTER 18 0.0003
815 PULMONARY OEDEMA 14 0.0003
816 SEROTONIN SYNDROME 6 0.0003
817 CHROMATURIA 7 0.0003
818 SWELLING 29 0.0003
819 MUSCLE TIGHTNESS 5 0.0003
820 SKIN FISSURES 6 0.0003
821 ARTHROPATHY 17 0.0003
822 SPEECH DISORDER 16 0.0003
823 LABORATORY TEST ABNORMAL 9 0.0003
824 OSTEONECROSIS 10 0.0003
825 DRUG EFFECT INCOMPLETE 11 0.0003
826 DISORIENTATION 12 0.0003
827 EAR INFECTION 8 0.0003
828 VIRAL INFECTION 10 0.0003
829 LIP SWELLING 10 0.0003
830 PARAESTHESIA 47 0.0003
831 MYOCARDIAL INFARCTION 52 0.0003
832 FULL BLOOD COUNT DECREASED 6 0.0003
833 PRODUCT PHYSICAL ISSUE 6 0.0003
834 ARRHYTHMIA 14 0.0003
835 ARTHRALGIA 122 0.0003
836 GINGIVAL BLEEDING 4 0.0003
837 ANXIETY 83 0.0003
838 GASTRIC DISORDER 10 0.0003
839 ADVERSE DRUG REACTION 26 0.0003
840 CARDIO-RESPIRATORY ARREST 12 0.0003
841 EOSINOPHILIA 5 0.0003
842 DRUG ERUPTION 5 0.0003
843 DIALYSIS 4 0.0003
844 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
845 BRONCHOSPASM 4 0.0003
846 PNEUMONIA ASPIRATION 7 0.0003
847 TOXICITY TO VARIOUS AGENTS 47 0.0003
848 LACTIC ACIDOSIS 9 0.0003
849 CELLULITIS 14 0.0003
850 FEELING HOT 17 0.0003
851 VAGINAL HAEMORRHAGE 12 0.0003
852 MENTAL DISORDER 12 0.0003
853 CARDIOVASCULAR DISORDER 7 0.0003
854 APATHY 4 0.0003
855 IMPAIRED HEALING 9 0.0003
856 ORAL PAIN 6 0.0003
857 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
858 MEMORY IMPAIRMENT 36 0.0003
859 INJECTION SITE REACTION 18 0.0003
860 TINNITUS 12 0.0003
861 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
862 UNDERDOSE 19 0.0003
863 INFLUENZA 29 0.0003
864 MYALGIA 44 0.0003
865 VISUAL IMPAIRMENT 32 0.0003
866 INJECTION SITE ERYTHEMA 32 0.0003
867 CHOKING 5 0.0003
868 ORAL HERPES 5 0.0003
869 BRAIN FOG 4 0.0003
870 HYPOAESTHESIA 38 0.0003
871 INJECTION SITE PRURITUS 17 0.0003
872 DYSPHAGIA 24 0.0003
873 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
874 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
875 HEPATIC CANCER 6 0.0002
876 BLISTER 14 0.0002
877 VISION BLURRED 34 0.0002
878 PAIN IN JAW 7 0.0002
879 TREMOR 41 0.0002
880 INJECTION SITE URTICARIA 6 0.0002
881 OSTEONECROSIS OF JAW 6 0.0002
882 FEELING ABNORMAL 58 0.0002
883 VISUAL ACUITY REDUCED 8 0.0002
884 FUNGAL INFECTION 8 0.0002
885 SURGERY 14 0.0002
886 MOBILITY DECREASED 17 0.0002
887 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
888 CATARACT 14 0.0002
889 APHASIA 7 0.0002
890 DIPLOPIA 6 0.0002
891 DEAFNESS 6 0.0002
892 BURNING SENSATION 16 0.0002
893 GASTRITIS 6 0.0002
894 COVID-19 40 0.0002
895 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
896 SNEEZING 5 0.0002
897 GASTROENTERITIS VIRAL 4 0.0002
898 MIGRAINE 21 0.0002
899 LEUKOPENIA 11 0.0002
900 PRODUCT AVAILABILITY ISSUE 5 0.0002
901 BONE DISORDER 4 0.0002
902 WHEEZING 13 0.0002
903 LUNG NEOPLASM MALIGNANT 9 0.0002
904 SKIN LESION 6 0.0002
905 AGITATION 16 0.0002
906 NIGHT SWEATS 7 0.0002
907 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
908 CONJUNCTIVITIS 4 0.0002
909 NECK PAIN 12 0.0002
910 INCORRECT DOSE ADMINISTERED 49 0.0002
911 CARDIAC DISORDER 20 0.0002
912 INJECTION SITE BRUISING 17 0.0002
913 ASTHMA 24 0.0002
914 FOOT FRACTURE 4 0.0002
915 CEREBROVASCULAR ACCIDENT 35 0.0002
916 MENTAL IMPAIRMENT 5 0.0002
917 NEURALGIA 5 0.0002
918 ARTHRITIS 16 0.0002
919 IRRITABILITY 12 0.0002
920 CARDIAC FAILURE CONGESTIVE 16 0.0002
921 PRODUCT DOSE OMISSION 13 0.0002
922 ANAPHYLACTIC REACTION 11 0.0002
923 NEUTROPHIL COUNT DECREASED 8 0.0002
924 DRY SKIN 26 0.0002
925 ERECTILE DYSFUNCTION 5 0.0002
926 EXPOSURE DURING PREGNANCY 12 0.0002
927 COGNITIVE DISORDER 9 0.0002
928 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
929 INSOMNIA 51 0.0002
930 DERMATITIS 4 0.0002
931 PRURITUS 73 0.0002
932 EYE SWELLING 7 0.0002
933 SINUSITIS 19 0.0002
934 AMNESIA 12 0.0002
935 EYE PRURITUS 6 0.0002
936 RASH 77 0.0002
937 DEPRESSION 40 0.0002
938 DYSKINESIA 7 0.0002
939 BLOOD CHOLESTEROL INCREASED 8 0.0002
940 DYSPHONIA 10 0.0002
941 ACUTE MYOCARDIAL INFARCTION 5 0.0002
942 PSYCHOTIC DISORDER 5 0.0002
943 RASH PRURITIC 9 0.0002
944 INTERSTITIAL LUNG DISEASE 8 0.0002
945 RESTLESSNESS 6 0.0002
946 CEREBRAL INFARCTION 4 0.0002
947 LUNG DISORDER 8 0.0002
948 MOOD SWINGS 5 0.0002
949 COLITIS ULCERATIVE 7 0.0002
950 ECZEMA 8 0.0002
951 EYE DISORDER 5 0.0002
952 ADVERSE EVENT 14 0.0002
953 HYPERSENSITIVITY 28 0.0002
954 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
955 SKIN DISORDER 5 0.0001
956 ABORTION SPONTANEOUS 6 0.0001
957 EMOTIONAL DISTRESS 18 0.0001
958 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
959 UNEVALUABLE EVENT 11 0.0001
960 URTICARIA 24 0.0001
961 SKIN EXFOLIATION 12 0.0001
962 BRONCHITIS 10 0.0001
963 INFLUENZA LIKE ILLNESS 11 0.0001
964 NO ADVERSE EVENT 24 0.0001
965 SKIN IRRITATION 6 0.0001
966 DRUG ADMINISTRATION ERROR 4 0.0001
967 EMOTIONAL DISORDER 4 0.0001
968 BREAST CANCER 12 0.0001
969 RENAL CANCER 6 0.0001
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
972 PRODUCT STORAGE ERROR 9 0.0001
973 INTENTIONAL PRODUCT MISUSE 9 0.0001
974 MUSCULOSKELETAL STIFFNESS 9 0.0001
975 INJURY 7 0.0001
976 PRODUCT QUALITY ISSUE 13 0.0001
977 DRUG EFFECT DECREASED 5 0.0001
978 DISTURBANCE IN ATTENTION 5 0.0001
979 ACNE 7 0.0001
980 ANGIOEDEMA 4 0.0001
981 DRUG DEPENDENCE 13 0.0001
982 PROSTATE CANCER 6 0.0001
983 DRUG DOSE OMISSION 12 0.0001
984 EYE PAIN 4 0.0001
985 HALLUCINATION 5 0.0001
986 SUICIDAL IDEATION 6 0.0001
987 RHEUMATOID ARTHRITIS 6 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
989 OVERDOSE 10 0.0000
990 DRUG WITHDRAWAL SYNDROME 4 0.0000